Sacklers, States Near Bigger Purdue Pharma Opioid Settlement
- Parties discuss deal for ‘substantial’ additional contribution
- Mediator asks to extend talks to Feb. 7 to reach agreement
This article is for subscribers only.
Members of the billionaire Sackler family that own Purdue Pharma LP are close to a deal that would increase their contribution to the OxyContin maker’s sweeping opioid settlement, court papers show.
The family and a handful of state attorneys general who have been opposing Purdue’s opioid settlement are nearing a deal that would provide a “substantial” additional contribution on top of the $4.325 billion the company’s owners already pledged, according to the court documents.